Background: The aim of this study was to compare the clinical outcomes and retear rate of arthroscopic superior capsular reconstruction (SCR) with dermal allograft following structural failure of a previous rotator cuff repair, with a cohort of primary SCRs.

Methods: This was a retrospective comparative study with a study group comprising 22 patients who were followed up at a minimum of 24 (mean, 41; range, 27-65) months after SCR with dermal allograft performed for structural failure of a previous rotator cuff repair. The control group included 13 patients who previously underwent a primary SCR using dermal allograft and were followed up for 24 months. Clinical outcome measures comprised range of motion, the American Shoulder and Elbow Surgeons score, and the Western Ontario Rotator Cuff (WORC) Index. Radiological outcomes included the acromiohumeral interval and graft integrity on magnetic resonance imaging at one year. Logistic regression was used to determine whether SCR being undertaken as either a primary or revision procedure influenced functional outcomes or retear rate.

Results: The mean age at the time of surgery was 58 (range, 39-74) years for the study group and 60 (range, 48-70) years for the control group. Forward flexion improved from a mean of 117° (range, 7°-180°) preoperatively to 140° (range, 45°-170°) postoperatively ( = .11), and external rotation increased from a mean of 31° (range, 0°-70°) preoperatively to 36° (range, 0°-60°) postoperatively ( = .23). The American Shoulder and Elbow Surgeons score improved ( = 0) from a mean of 38 (range, 12-68) to 73 (range, 17-95), and the WORC Index improved ( = 0) from a mean of 29 (range, 7-58) to 59 (range, 30-97). Following SCR, there was no significant change in the acromiohumeral interval. The graft was intact in 42% of cases on magnetic resonance imaging and none of the retears underwent further surgery. Compared to revision SCR, primary SCR resulted in a significant improvement in forward flexion ( = .001), external rotation ( = 0), and WORC Index ( = .019). Logistic regression demonstrated that SCR performed as a revision procedure was associated with a higher retear rate ( = .006) and worse forward flexion ( = .009) and external rotation ( = .008).

Conclusion: SCR using human dermal allograft following structural failure of a previous rotator cuff repair can lead to an improvement in clinical outcomes but the results are inferior to primary procedures.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328778PMC
http://dx.doi.org/10.1016/j.jseint.2023.03.023DOI Listing

Publication Analysis

Top Keywords

dermal allograft
20
rotator cuff
20
scr dermal
12
structural failure
12
failure previous
12
previous rotator
12
cuff repair
12
range
12
forward flexion
12
external rotation
12

Similar Publications

Rotator cuff tears are a common cause of shoulder pain and dysfunction. Recent and historical reports suggest that a sizable percentage of patients may experience a retear of the rotator cuff despite surgical intervention. Multiple biological and mechanical factors can influence outcomes after rotator cuff surgery, including patient age, rotator cuff tear size, chronicity, and rotator cuff tissue quality.

View Article and Find Full Text PDF

Background: Acellular dermal matrices (ADM) are an adjunct in implant-based breast reconstruction. While clinical outcomes have generally been equivocal between brands, a cost analysis between these brands has yet to be conducted. This study reports a single, academic institution's experience with 2 ADM brands in breast reconstruction and provides data on clinical and financial outcomes.

View Article and Find Full Text PDF

Purpose: To assess the variability in graft biomechanical properties of an acellular human dermal matrix patch.

Methods: A total of 22 strips obtained from 6 separate graft specimens (AlloPatch HD) were tested. Load elongation properties after cyclic loading, including ultimate load at break, energy at break, and extension at break, were tested and compared by graft thickness.

View Article and Find Full Text PDF

Advances in preparation of acellular human dermis for tissue banking and transplantation.

Cell Tissue Bank

December 2024

NHS Blood and Transplant, Tissue Services R&D, 14 Estuary Banks, Speke, Liverpool, L24 8RB, UK.

Article Synopsis
  • Non-healing wounds lead to significant costs for the NHS, totaling over £5.6 billion annually, prompting the use of skin allografts for better infection protection.
  • A study aimed to validate a new decellularisation method using Benzonase, a single enzyme, to remove DNA from donor skin, which could simplify the process compared to the current dual-enzyme approach.
  • Results showed that both Benzonase and the existing method effectively removed DNA without significant differences in their performance, demonstrating Benzonase's non-toxicity and potential as a cost-effective alternative in wound treatment.
View Article and Find Full Text PDF
Article Synopsis
  • - Diabetic foot ulcers (DFUs) are a significant and expensive issue for diabetes patients, leading to increased healthcare costs and morbidity.
  • - A study compared two treatments for DFUs: a high-purity type-I collagen skin substitute (HPTC) and dehydrated human amnion/chorion membrane (dHACM) over four weeks, with 28 patients participating.
  • - Results showed that HPTC led to better healing outcomes, with 85.71% of patients achieving at least 50% wound size reduction compared to 50% for dHACM, suggesting HPTC may be a more effective treatment for chronic DFUs.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!